By John Schroyer The District of Columbia's medical cannabis companies have been ramping up in the past month, largely because of new business-friendly regulations that have reshaped the future in terms of possible market size. But those companies still face big questions, especially with regard to expansion and uncertainty over the customer base's potential size. Read More